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Abstract
Background: Having friends is associated with more favourable clinical outcomes and a higher quality of life in mental
disorders. Patients with schizophrenia have fewer friends than other mentally ill patients. No large scale studies have
evaluated so far what symptom dimensions of schizophrenia are associated with the lack of friendships.
Methods: Data from four multi-centre studies on outpatients with schizophrenia and related disorders (ICD F20-29) were
included in a pooled analysis (N = 1396). We established whether patients had close friends and contact with friends by
using the equivalent items on friendships of the Manchester Short Assessment of Quality of Life or of the Lancashire Quality
of Life Profile. Symptoms were measured by the Brief Psychiatric Rating Scale or by the identical items included in the
Positive and Negative Syndrome Scale.
Results: Seven hundred and sixty-nine patients (55.1%) had seen a friend in the previous week and 917 (65.7%) had
someone they regarded as a close friend. Low levels of negative symptoms and hostility were significantly associated with
having a close friend and contact with a friend. Overall, almost twice as many patients with absent or mild negative
symptoms had met a friend in the last week, compared with those with moderate negative symptoms.
Conclusions: Higher levels of negative symptoms and hostility are specifically associated with the lack of friendships in
patients with psychotic disorders. These findings suggest the importance of developing effective treatments for negative
symptoms and hostility in order to improve the probability of patients with schizophrenia to have friends.
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Introduction
Friendship can be defined as a ‘‘distinctively personal relation-
ship that is grounded in a concern on the part of each friend for
the welfare of the other, for the other’s sake, and that involves
some degree of intimacy’’ [1]. The definition of friendship can
vary significantly in different geographical and cultural contexts
but also due to personal factors, (attachment style, gender,
previous experiences) [2]. Yet, the role of friends as a source of
social support is becoming increasingly important in contemporary
society [3–4], as a consequence of changes in family structure and
of the increased number of people living alone [5]. It has been
widely recognized that having friends provides patients with
a mental disorder with emotional and practical support and helps
them to cope with life stressors [6]. Relationships with friends may
also positively affect physical and mental health by improving
health behaviours and help seeking and confer psychological
benefits for depression, self efficacy, self esteem, coping, and
morale [7].
People with psychotic disorders tend to have fewer friends and
social relationships compared to the general population and to
patients with other mental and physical disorders [2–8].
While many factors, such as deficits in neurocognition and
social cognition, unemployment, financial difficulties and stigma
are likely to reduce patients’ social functioning [9–11], different
symptoms of psychotic disorders have been linked to patients’
difficulties in establishing and maintaining social contacts. Social
withdrawal of patients with psychotic disorders has been suggested
to be an attempt at avoiding excessive stimulation and sub-
sequently relapse. Hansen and colleagues [12] proposed a distinc-
tion between passive social withdrawal, which may be mostly
related to negative symptoms, and active social avoidance, which
has been linked to positive symptoms. The lack of motivation
which is part of the negative symptoms dimension may play
a significant role in reducing contact with friends [13]. As regards
the other symptom domains of psychosis, depressive and anxiety
symptoms may reduce patients’ drive towards social activities and
contacts [14–15]; thought disorders may influence patients’
language and ability to share their thoughts and feelings with
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others [6]; high levels of excitement and activation may make
patients appear unpredictable and dangerous so that others avoid
contact and longer relationships with them [16]; high levels of
hostility have been found to predict worse social integration,
defined as number of contacts and significant relationships [17].
However, although many studies have assessed the relationship
between psychotic symptoms and patients’ global social networks,
few data are available on the associations of symptoms specifically
with friendship, with its characteristics of an intimate and
supportive relationship.
To our knowledge, only one mixed-methods study, carried out
on 151 patients with schizophrenia in south England, has
specifically focused on relationships with friends of patients with
schizophrenia [2] finding an association between levels of both
positive and negative symptoms and contacts with a friend. Other
studies [18–19] found a moderate correlation of negative
symptoms and hostility with social functioning and involvement
in leisure activities in the community that were correlated with
friendships in relatively small samples (n = 56 and n = 263,
respectively).
Evidence from larger samples is necessary to further understand
how different symptoms are specifically associated with contacts
with friends. Given the protective effects of friendship, interven-
tions to improve patients’ friendships and, as a consequence, social
support, clinical outcomes, and quality of life may need to consider
specific symptom dimensions.
This study assessed, through a pooled analysis of individual
patient data from four Europe-wide multicentre studies, the
association of five symptom dimensions of psychotic disorders
(negative symptoms, thought disorders, depression/anxiety symp-
toms, activation and hostility) with having a close friend and
contacts with friends in the community. As age and gender have
been found to be associated with patients’ social contacts in
previous studies [20–22], we also investigated whether the
associations between symptoms and having a friend and contacts
with friends were similar for males and females and in different age
groups. Initially, our analysis included all patients with psychotic
disorders, diagnosed according to ICD-10 criteria (F20–29). In
a second phase, we performed a sensitivity analysis including only
patients with schizophrenia (F20).
Methods
Sample
For this study we analysed data from four multi-centre studies,
i.e. one cluster randomized controlled trial and three prospective
observational studies.
The DIALOG study [23] was a cluster randomized controlled
trial testing the effect of a computer mediated intervention
structuring patient-clinician communication in community mental
health care. It was conducted with outpatients at sites in six
European countries (United Kingdom, Spain, Netherlands,
Sweden, Germany, Switzerland). The baseline data were analysed
(n = 502), which were obtained before randomization and hence
not affected by the study intervention.
The ‘‘Nordic multicentre study’’ [24] was a multi-centre cross-
sectional study of subjective quality of life in people with
schizophrenia living in the community, carried out in five
Scandinavian countries (Sweden, Denmark, Finland, Iceland,
Norway). Data from 341 patients were included in the analysis.
The ‘‘EUNOMIA’’ study [25] was an observational prospective
study in 12 European countries to assess outcomes of coercive
treatments and influencing factors. In our study, we took data from
the last follow-up interview (three months after admission) to have
a large sample of patients who had been discharged and were
living in the community. Only data from centres where evaluation
of patients’ quality of life had been performed through Manchester
Short Assessment of Quality of Life (MANSA) could be included
in the analysis (Germany, Czech Republic, Lithuania, Poland,
Slovakia, Sweden) (n = 352). UK data were excluded to avoid
duplicates with the InvolvE [26] study that was conducted in the
same period in the same inpatient wards.
The ‘‘InvolvE’’ study [26] was an observational prospective
study on outcomes of involuntary hospitalizations in 22 hospitals
in England. For our study we took data from the last follow-up
assessment (1 year after the index admission), again to have a large
sample of patients who lived in the community (n = 201).
Rationale, methods and findings of the studies have been
published elsewhere [23–26]. The inclusion criteria for patients
assessed in the course of these four studies were: 1) having
a diagnosis of schizophrenia, schizotypal, or delusional disorders
(F20–F29) according to ICD-10 [27]; diagnoses were made using
ICD-10 criteria because they are broader than DSM-IV criteria
and include all range of psychotic disorders (i.e. schyzotypal
disorder is included among psychotic disorders in ICD-10 whilst in
DSM-IV it is considered a personality disorder) [28]; 2) not having
been hospitalized in the seven days before the interview, in order
to assess friendships in the community using questions relating to
behaviour in the last week; 3) having responded to the relevant
items on the Manchester Short Assessment of Quality of Life
(MANSA) and the Lancashire Quality of Life Profile (LQOLP).
Ethics Statement
All studies included in this pooled analysis have obtained
approval of relevant ethics committees, and all patients provided
written informed consent.
Measures
Studies used either the Lancashire Quality of Life Profile
(LQOLP) or the Manchester Short Assessment of Quality of Life
(MANSA) instruments which contain equivalent items for assess-
ing patients’ friendships [29–30]. For the purposes of our study, we
analysed two items on friendships from MANSA and LQOLP.
One reflected a behavioural criterion (‘‘have you seen a friend
within the last week, i.e. visited a friend, been visited by a friend, or
met a friend outside both your home and work?’’), and the other
a subjective appraisal of friendship (‘‘do you have anyone whom
you would call a close friend?’’). We chose to study both
a subjective and an objective criterion of friendship because we
wanted to assess contacts with friends from both perspectives.
Some patients may report having close friends, but not feel able to
actually see them due to symptoms like motor retardation, lack of
motivation or depressive symptoms. Other patients with specific
symptoms (i.e. paranoid delusions or suspiciousness) may report no
close friends even though their social network is not totally
compromised. Both questions are answered with no ( = 0) or yes
( = 1). We focused on these two questions as they are brief,
straightforward to understand, and simple to answer so that a wide
range of patients can respond including those with high symptom
levels and low motivation. This was seen as important to limit
a selection bias with lower response rates in highly symptomatic
patients. Data on these questions were available in all data sets
allowing us to take full advantage of a pooled analysis.
In two studies [25–26] symptoms were assessed on the 24-item
Brief Psychiatric Rating Scale [31] and in the other two [23–24]
on the Positive and Negative Syndrome Scale (PANSS) [32].
PANSS items used in this analysis are identical to BPRS items.
The Cohen kappa’s values for the inter-rater reliability of
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symptom assessments on these scales ranged from 0.71 to 0.90 in
the four studies. This allowed computation of BPRS-18 items and
scores of five BPRS-18 subscales: 1) anxiety/depression (items:
anxiety, guilt, depression, somatic); 2) negative symptoms (items:
blunted affect, emotional withdrawal, motor retardation); 3)
thought disorders (items: thought content, conceptual disorgani-
zation, hallucinatory behavior, grandiosity); 4) activation (items:
excitement, tension, mannerisms-posturing); and 5) hostility (items:
hostility, uncooperativeness, suspiciousness) [33]. Additionally we
obtained data on patients’ age and gender from all studies.
Statistical Analysis
Stata 12 for Windows was used for all data analyses [34].
Descriptive statistics for the distribution of all considered variables
in the total sample were calculated.
Four datasets were pooled to identify main effects of symptom
domains and also interaction effects of symptom domains with age,
gender or both. A ‘‘pooled analysis’’ [35–36] was conducted. This
approach enables a more precise estimate of effects of influential
factors and takes into account confounding factors such as
patients’ age and gender and the heterogeneity of centres. A
further advantage is that the same statistical model could be used
with data from methodologically diverse studies and to test
interactions with specific patients’ characteristics (in this case age
and gender).
The correlation between the behavioural item, i.e. contact with
friends in the last week, and the subjective item, i.e. patients’
subjective appraisal of having a close friend was explored by the
phi test. Univariable and multivariable logistic mixed models,
adjusted for heterogeneity across centres and studies, were used to
identify the factors associated with behavioural and subjective item
for friendship. The multivariable model, adjusted for confounding
factors (patients’ age and gender), included all BPRS subscales. In
this three-level model, patient-level measurements (level-1) were
treated as nested within centres (level-2), and centres as nested
within studies (level-3). To illustrate the size and clinical relevance
of possible associations between symptom domains and friendship,
we divided average scores of the given BPRS subscale in six
intervals (i.e. 1, from 1 to 2, 2 to 3, 3 to 4, 4 to 5, 5 to 6) and
showed the percentages of patients who had seen a friend in the
last week and had a close friend for each symptom interval. For
each interval, the higher number was included in the lower
interval (i.e. 2 was included in the interval from 1 to 2) and there
were no values higher than 6. Then, dichotomous variables were
created for each subscale that had a statistically significant
association with the two friendship items. In these dichotomous
variables all the values of BPRS subscales that were lower than 2
(with 2 included) were coded as ‘‘10 and all the values that were
higher than 2 as ‘‘00. The univariable associations of these
variables with friendship items were tested by mixed logistic
regression models, adjusted for heterogeneity of centres and
studies.
Two-way interactions for age and gender were tested to
establish whether they influenced associations between BPRS
subscales and patients’ contact with friends. Statistical significance
of interaction terms was assessed using Wald tests.
Since the sample contained patients with different diagnoses
within the spectrum of schizophrenia and related disorders, we
conducted a sensitivity analysis, repeating the analyses in the
pooled sample only with those patients who had a diagnosis of
schizophrenia (F20 according to the ICD-10).
Results
Patient Characteristics
Across the studies, a total of 1396 patients met the inclusion
criteria (n = 502 from the DIALOG study; n = 341 from the
Nordic Multicentre study; n = 352 from the EUNOMIA study;
n = 201 from the InvolvE study). Patients were predominantly
male (844, 60.5%), with a mean age of 39.9 years (SD = 11.1). The
age span in years was 18–64 in EUNOMIA study (median = 39,
quartiles = 29–49), 18–65 in DIALOG study (median = 42,
quartiles = 33.5–50), 18–64 in the INVolvE study (median = 36,
quartiles = 26–45) and 20–55 in the Nordic Multicentre study
(median = 40, quartiles = 32–46).
Seven hundred and sixty-nine patients (55.1%) had seen a friend
in the previous week and 917 (65.7%) had someone they regarded
as a close friend. Overall patients showed low scores on different
BPRS subscales and the distribution of these scores were skewed to
the left. The mean scores of the BPRS subscales were: 2.1
(SD = 0.9) on the depression/anxiety subscale; 1.9 (SD = 0.9) on
the negative symptoms subscale; 1.9 (SD = 1.0) on the thought
disorders subscale; 1.5 (SD = 0.6) on the activation subscale; 1.5
(SD = 0.7) on the hostility subscale.
The main socio-demographic and clinical characteristics of the
individual studies and samples and of the pooled sample are
reported in Table 1.
Associations of Symptom Domains and Friendship Items
The behavioural (having seen a friend) and subjective (having
a close friend) items on friendship were significantly correlated
(phi = .589, p,.001).
a. Contact with friends in the previous week. As shown in
Table 2, the scores of all BPRS subscales were univariably
associated with fewer contacts with friends in the last week.
However, when controlling for all BPRS subscales, patients’ age
and gender and adjusting for random effects of heterogeneity of
centres and studies, only higher levels of negative symptoms and
hostility were associated with patients’ contact with friends in the
previous week with odds ratios (OR) of.693 (95% confidence
interval (95% CI) = .602–.797, p,.001) and.823 (95% CI = .680–
.996, p = .046), respectively; younger patients more often had
contacts with friends in the previous week (OR age = 0.980, 95%
CI = 0.970–0.990, p,.001). The multivariable model is reported
in Table 3.
b. Having a close friend. The univariable and multivariable
models that tested the associations between symptom domains and
the subjective appraisals of patients of having a close friend are
reported in Table 4 and Table 5.
Higher levels of all the symptom domains, with the exception of
depression/anxiety symptoms, were univariably associated with
the absence of a close friend. When controlling for age and gender
and adjusting for heterogeneity of centres and studies, only the
associations of the absence of close friendships with higher levels of
negative symptoms (OR = .676; 95% CI = .583–.783; p,.001) and
hostility (OR = .813; 95% CI = .670–.988; p = .037) held true.
Younger patients were more likely to have a close friend (OR
age = .983; 95% CI = .972–.994; p = .002). Male patients reported
less frequently than female patients that they had a close friendship
(OR = .758; 95% CI = .588–.977; p = .032).
Friendship Items and BPRS Sub-scales Intervals
The number and percentage of patients who had contact with
friends in the previous week and who stated that they had a close
friend are reported in Table 6 and Table 7 for each of the six
Symptoms and Contacts with Friends in Psychosis
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intervals of the BPRS negative symptoms and BPRS hostility
subscales.
a. Negative symptoms. Patients with very low levels of
negative symptoms (lower than ‘‘2’’ at BPRS negative symptoms
subscale) had almost double the odds of having met a friend in the
previous week (OR = 1.745; IC 95% = 1.399–2.176, p,.001) and
of having a close friend (OR = 1.838; IC 95% = 1.461–2.313,
p,.001) compared to those with higher levels of negative
symptoms. The odds ratios are adjusted for heterogeneity of
centres and studies.
b. Hostility. Patients with very low levels of hostility (lower
than ‘‘2’’ on BPRS hostility symptoms subscale) had higher odds of
having met a friend in the previous week (OR = 1.520; 95%
CI = 1.139–2.028, p = .004) and of having a close friend
(OR = 1.498; 95% CI = 1.117–2.011, p = .007) compared to those
with higher levels of hostility. The odds ratios are adjusted for
heterogeneity of centres and studies.
c. Patients with low or moderate-high levels of both
negative symptoms and hostility. Among the 770 patients
who had very low or absent levels both of negative symptoms and
hostility (BPRS subscale scores lower than two), 477 (61.9%) had
seen a friend in the last week and 549 (71.3%) had someone they
regarded as a close friend.
Patients with at least low-moderate levels of both negative
symptoms and hostility (BPRS subscales score higher than two)
were 138. Among them, 57 (40.6%) had seen a friend in the last
week and 73 (52.1%) had someone they regarded as a close friend.
Table 1. Characteristics of the four included studies and samples.
Study sample DIALOG study19
Nordic multicentre
study20 EUNOMIA study21 InvolvE study22 Total sample
Study sites UK, Spain, Netherlands,
Sweden, Germany,
Switzerland
Sweden, Denmark,
Finland, Iceland,
Norway
Germany, Poland, Slovakia,
Czech Republic, Lithuania,
Sweden
England -
Sample size1 502 341 352 201 1396
Measure2 MANSA LQOLP MANSA MANSA –
Study design Randomized controlled trial Prospective-observational Prospective-observational Prospective-observational –
Friend seen in the
last week, yes, n (%)
303 (60.4) 159 (46.5) 205 (58.2) 103 (51.2) 769 (55.1)
Close friendship
available, yes, n (%)
321 (63.9) 223 (65.2) 239 (67.9) 135 (67.2) 917 (65.7)
Patients’ age, mean
(sd)
42.1 (11.4) 38.9 (8.7) 39.7 (11.8) 36.5 (11.4) 39.9 (11.1)
Patients’ gender,
female, n (%)
169 (33.7) 133 (38.9) 192 (54.5) 59 (29.4) 552 (39.5)
BPRS – anxiety/
depression subscale
score, mean (sd)
2.3 (0.9) 2.3 (0.9) 1.8 (0.8) 2.1 (1.0) 2.1 (0.9)
BPRS – negative
symptoms subscale
score, mean (sd)
2.1 (0.9) 2.0 (0.8) 1.7 (0.8) 1.7 (0.8) 1.9 (0.9)
BPRS – thought
disorders subscale
score, mean (sd)
2.1 (1.0) 2.0 (1.0) 1.4 (0.6) 1.8 (1.1) 1.9 (1.0)
BPRS – activation
subscale score, mean
(sd)
1.4 (0.6) 1.9 (0.8) 1.3 (0.4) 1.4 (0.6) 1.5 (0.6)
BPRS – hostility
subscale score, mean
(sd)
1.4 (0.6) 1.7 (0.8) 1.4 (0.6) 1.7 (0.9) 1.5 (0.7)
1Sample size refers to included patients with an ICD-10 clinical diagnosis of schizophrenia, schizotypal, or delusional disorders, for which BPRS-18 and MANSA/LQOLP
items on friendship scores were available.
2LQOLP, Lancashire Quality of Life Profile; MANSA, Manchester Short Assessment of Quality of Life.
doi:10.1371/journal.pone.0050119.t001
Table 2. Univariable mixed model analyses of associations
between symptoms and having seen a friend in the last week
as a dependent variable adjusted for studies and centres
within studies (21 centres, 4 studies, 1396 patients).
Odds ratio
Odds ratio
(95% CIa) P
BPRS - depression/anxiety
subscale
.856 .759–.966 .012
BPRS - negative symptoms sub
scale
.618 .538–.710 ,.001
BPRS - thought disorder sub
scale
.806 .715–.907 ,.001
BPRS - activation sub scale .690 .570–.835 ,.001
BPRS - hostility sub scale .714 .607–.840 ,.001
Patients’ age .979 .970–.989 ,.001
Patients’ gender .810 .648–1.013 .065
aCI = Confidence Interval.
doi:10.1371/journal.pone.0050119.t002
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Interaction Effects of Symptoms with Age and Gender on
the Associations with Friendship Items
Contacts with friends in the previous week. The associ-
ation of higher levels of negative symptoms with contacts with
friends in the last week was neither influenced by age (Wald test
value Z =20.35, p = .724) nor by gender (Z =21.49, p = .135).
Similarly, no influence of age and gender on the association of
higher levels of hostility with contacts with friends was found
(Wald test values were Z = 0.75, p = .452 for age and Z = 1.73,
p = .084 for gender, respectively).
Having a Close Friend
The association of higher levels of negative symptoms with
having no close friends was not influenced by age (Z =20.60;
p = .546) or gender (Z =20.25; p = .806). The interaction of
gender on the association of hostility with having no close friends
was not statistically significant (Z = 1.28; p = .201). However, in
younger patients the association between hostility and absence of
close friendships was stronger (Z = 2.68, p = .007).
Sensitivity Analysis only with Patients with Schizophrenia
When we repeated the analyses in the pooled sample only with
those patients who met the criteria for schizophrenia (F20)
(n = 1019), the association of higher levels of negative symptoms
and hostility with contacts with friends in the last week and the
subjective appraisals of having a close friend remained statistically
significant. No other symptom domain was significantly associated
with friendships in the multivariable analysis. No interactions
between symptoms and socio-demographic variables were found.
In particular, the interaction between hostility levels and age, that
was statistically significant in the global sample, failed to reach
statistical significance in the subsample of patients with schizo-
phrenia.
Discussion
Main Results
This is the largest study to date analyzing how specific psychotic
symptoms are associated with social contacts of patients with
schizophrenia related disorders and the first one focussing
specifically on friendships, as a specific and relevant sub-category
of social contacts.
Higher levels of negative symptoms and hostility are associated
with fewer contacts with friends and absence of close friendships.
The association between negative symptoms and contacts with
friends is more marked in male patients. Depression/anxiety
symptoms, thought disorders and levels of activation were only
univariably associated with patients’ friendships. When the
associations were adjusted for the influence of other symptoms,
no significant association was found between depression/anxiety
symptoms, thought disorders and activation and friendships.
Despite the suggestion that all symptoms of schizophrenia are
likely to have an impact on patients’ social relationships [6,9,12–
19], this study showed that levels of negative symptoms and
hostility are specifically associated with the disruption of more
intimate social relationships, i.e., friendships, that can be
important sources of social support. The univariable association
of other symptoms with friendship may mainly reflect the overall
severity of psychotic symptoms.
Comparison with the Available Literature
We found a high number of patients did not have a close friend
and did not see any friend in the previous week, which is in line
Table 3. Multivariable mixed model analysis of associations between symptoms and having seen a friend in the last week as
a dependent variable adjusted for studies and centres within studies (21 centres, 4 studies, 1396 patients).
Adjusted for BPRS-18 subscales, patients’ age and gender
Odds ratio Odds ratio (95% CIa) P
BPRS - depression/anxiety subscale .983 .860–1.124 .804
BPRS - negative symptoms sub scale .693 .602–.797 ,.001
BPRS - thought disorder subscale .971 .847–1.114 .679
BPRS - activation sub scale .870 .708–.1.070 .186
BPRS - hostility sub scale .823 .680–.996 .046
Patients’ age .980 .970–.990 ,.001
Patients’ gender .835 .659–1.058 .135
Sigma_u .226 .093–.551
Rho .015 .003–.084
aCI = Confidence Interval.
doi:10.1371/journal.pone.0050119.t003
Table 4. Univariable mixed model analyses of association
between symptoms and likelihood of having a close friend as
a dependent variable adjusted for studies and centres within
studies (21 centres, 4 studies, 1396 patients)a.
Odds ratio
Odds ratio
(95% CIa) P
BPRS - depression/anxiety
subscale
.902 .795–1.023 .108
BPRS - negative symptoms
sub scale
.638 .555–.734 ,.001
BPRS - thought disorder sub
scale
.823 .729–.930 .002
BPRS - activation sub scale .761 .629–.921 .005
BPRS - hostility sub scale .712 .604–.838 ,.001
Patients’ age .984 .974–.994 .002
Patients’ gender .732 .577–.930 .011
aCI = Confidence Interval.
doi:10.1371/journal.pone.0050119.t004
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with the previous literature [2–8]. The proportion of patients with
psychosis without close friends is much higher than in the general
population (25% in a representative survey carried out in the
United States [37]). Our results suggest that the lack of friendships
in these patients is more related to negative symptoms and hostility
than to depressed mood, ‘‘active avoidance’’ and thought/
perception disorders.
The role of hostility in influencing the size of patients’ social
networks and their social functioning has already been reported by
other studies [17]. Our findings indicate that hostility levels may
also have an impact on closer relationships such as friendships. As
shown by the statistically significant interactions between age and
hostility levels in the global sample (not in the subsample of
patients with F20 diagnosis), such impact might be particularly
strong in the early phase of the disorders and in younger patients.
While the association of hostility levels with contacts with friends
may look rather intuitive, the link of negative symptoms with
friendships probably deserves some further exploration. Cognitive-
behavioural models [38] have suggested that social withdrawal
may constitute a ‘‘coping strategy’’ for reducing stress and arousal
levels. Such coping strategy, characterized by symptoms such as
blunted affect and emotional withdrawal, may limit current
distress; however, it could be maladaptive in the long term leading
to increased social isolation and poorer clinical and social
outcomes [2]. Furthermore, other symptoms included in the
negative symptom dimension, such as lack of motivation and
motor retardation, may reduce social engagement of these patients
and hamper their contacts even with people they consider as close
friends [13].
High levels of activation (i.e. excitement, tension, mannerism
and posturing) and thought disorders (i.e. thought content
disorders, conceptual disorganization, hallucinations and grandi-
osity) might lead other people to believe that patients are
unpredictable and, possibly, dangerous [16]. The results of this
study, however, do not support the hypothesis that levels of
activation and thought disorders determine patients’ difficulties in
having friends. In contrast to previous studies which established
a link between depressive symptoms in schizophrenia and deficits
in object relations and reality testing [39], a high level of anxiety/
depression symptom dimension was not associated with less
contacts with friends when controlling for other symptom
dimensions effect.
In our sample, younger patients were more likely to have had
recent contacts with friends than older patients. This finding might
be interpreted as a consequence of the progressive deterioration of
one’s social network related to psychotic disorders [40] that may
finally also affect the more intimate relationships, such as
friendship.
Table 5. Multivariable mixed model analysis of association between symptoms and likelihood of having a close friend as
a dependent variable adjusted for studies and centres within studies (21 centres, 4 studies, 1396 patients).
Adjusted for BPRS-18 subscales, patients’ age and gender
Odds ratio Odds ratio (95% CIa) P
BPRS - depression/anxiety subscale 1.005 .872–1.158 .944
BPRS - negative symptoms sub scale .676 .583–.783 ,.001
BPRS - thought disorder subscale .960 .832–1.107 .574
BPRS - activation sub scale .963 .772–.1.200 .738
BPRS - hostility sub scale .813 .670–.988 .037
Patients’ age .983 .972–.994 .002
Patients’ gender .758 .588–.977 .032
Sigma_u .290 .153–.547
Rho .025 .007–.083
aCI = Confidence Interval.
doi:10.1371/journal.pone.0050119.t005
Table 6. Contacts with friends of patients with different scores on the BPRS negative symptoms and hostility subscales.
BPRS subscales score Have you seen a friend in the last week?
Negative symptoms Hostility symptoms
Intervals Totala (n) Yesb (n) Yesc (%) Totala (n) Yesb (n) Yesc (%)
1 321 214 66.7 550 328 59.6
.1 and ,= 2 545 311 57.1 610 336 55.1
.2 and ,= 3 369 177 48.0 179 84 46.9
.3 and ,= 4 125 48 38.4 41 14 34.1
.4 and ,= 6 19 7 36.8 9 2 22.2
aNumber of patients at each interval of BPRS subscales score.
bNumber of patients at each interval of BPRS subscales score who reported to have seen a friend in the last week.
cPercentage of patients at each interval of BPRS subscales score who reported to have seen a friend in the last week.
doi:10.1371/journal.pone.0050119.t006
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Male patients had less frequently someone they regarded as
a close friend. This may be due to a greater fear of intimacy and
lower levels of emotional commitment in relationships of males,
documented in studies on clinical and non-clinical populations
[21,41] and related to culturally determined gender attitudes [42].
Substance misuse may also play a role in reducing social contacts
amongst male patients with psychosis, due to its higher prevalence
amongst this patient group and its association with higher
symptom levels [43].
Implications
Although the cross-sectional nature of the study does not allow
conclusions to be drawn on causal relationships, we found
significant associations of higher levels of negative symptoms and
hostility with lack of friendships. Despite suggestions that all
symptoms of psychotic disorders can have a role in patients’
difficulties in establishing and maintaining social relationships, the
levels of negative symptoms and hostility may be specifically
associated with the disruption of more intimate social relation-
ships, i.e. friendships, that can be important sources of social
support. It might be hypothesized that a full reduction of moderate
to severe symptom levels in these two domains might have
a relevant impact on the patient’s chances to have and meet
friends.
There is limited evidence on the effectiveness of available
treatments specifically for hostility. A range of antipsychotics have
been suggested as effective [44] in reducing hostility, but patients
with high levels of hostility symptoms frequently show a reduced
adherence to antipsychotic medication [45].
On the other hand, the treatment of negative symptoms is
particularly challenging. Intensive psychosocial treatment has been
found to have a beneficial effect on negative symptoms [46].
However, pharmacological and psychosocial therapies that are
usually available in mental health services show limited effective-
ness on this symptom dimension and the full remission is rarely
achieved in practice [47–48].
The limits in effectiveness of available therapies may pose
patients with high levels of these symptoms at high risk of poorer
psychological and physical health outcomes [7].
Furthermore, even among patients with no or very low levels of
both negative symptoms and hostility, about 38% did not see
a friend in the last week and 29% reported not having a close
friend. It is possible that other factors, such as impairment of
neuro-cognitive performance and deficits in social cognition [49],
may have a negative impact on social relationships of these
patients. Neurocognitive deficits such as significant impairments in
the domains of processing speed, verbal memory, executive
function, working memory, sustained attention and language can
be present in patients with psychotic disorders from the premorbid
phase onwards [50]. They may have a negative impact on
establishing social networks in the adolescence and early adult-
hood [51]. Also deficits in social cognition that are present in
patients with psychosis [49] may have a negative influence on their
social relationships independently from symptom severity. Finally,
the secondary consequences of psychotic disorders such as
unemployment, stigma and financial problems may reduce the
opportunities for these patients to engage in social activities and
establish relationships [11].
Strengths and Limitations
The large sample size of this study provided a substantial
statistical power for multivariable tests, including the testing of
interaction effects, and ensured the validity and generalisability of
both positive and negative findings. This is also the first
multicentre assessment of friendship as an intimate relationship,
with its potential to provide support to patients [6]. Both subjective
and behavioural items related to friendship were included and
their associations with symptoms were consistent. The assessments
were conducted in international multi-centre studies carried out in
different European countries on patients living in the community.
The analysis considered the possible heterogeneity of findings
between centres and studies. The inter-rater reliability of clinical
symptom assessments was high in all the studies (Cohen Kappa’s
values between 0.71 and 0.90).
However, some limitations should be noted: a) Study patients
were not representative of all patients in the given service.
Selection biases might have influenced the final scores of items on
friendship and of BPRS subscales. Nevertheless, the aim of the
study was to assess associations between clinical symptoms and
patients’ contacts with friends, and associations are usually more
robust towards selection bias than absolute levels [52]; b) The
definition of friendship was not provided to patients ‘‘a priori’’ but
was mainly based on patients’ own assessment of what friendship
is, which may vary among different individuals. Characteristics of
the nature of the friendship were not assessed, which might have
led to an over-estimation of the behavioural criterion. We cannot
exclude that friends seen in the last week might have been in some
cases simple acquaintances. However the correlation between
Table 7. Percentage of patients with different scores on the BPRS negative symptoms and hostility subscales who have a close
friend.
BPRS subscales score Do you have anyone you would call a close friend?
Negative symptoms Hostility symptoms
Intervals Totala (n) Yesb (n) Yesc (%) Totala (n) Yesb (n) Yesc (%)
1 321 247 77.7 550 392 71.3
.1 and ,= 2 545 366 67.2 610 388 63.6
.2 and ,= 3 369 216 58.5 179 105 58.7
.3 and ,= 4 125 67 53.6 41 21 55.3
.4 and ,= 6 19 8 42.1 9 5 55.6
aNumber of patients at each interval of BPRS subscales score.
bNumber of patients at each interval of BPRS subscales score who reported to have a close friend.
cPercentage of patients at each interval of BPRS subscales score who reported to have a close friend.
doi:10.1371/journal.pone.0050119.t007
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subjective and behavioural criteria and their association with the
same symptom domains contributes to confirm the validity of these
findings; c) Only patients with non-affective psychotic disorders
were included in this analysis; d) All included studies were
conducted in Europe, and the generalizability of the findings to
samples outside Europe needs to be explored; e) the associations of
friendship items with other variables such as stigma, neurocogni-
tive and social cognition disorders and secondary effects of
schizophrenia (unemployment, deficit in social motor coordina-
tion, financial problems, stigma) [9–12,53] could not be explored;
f) duration of illness and type of treatment received by patients
were not assessed in all included studies, therefore we could not
test the effects of these variables. However, patients’ age may be
regarded as a proxy variable for the duration of illness; g) Patients
were not in an acute phase and were living in the community
when the assessments were performed. Consequently, the BPRS
scores were generally low. We cannot exclude a possibility that the
contacts with friends may change significantly during acute phases
and fluctuate over the course of illness. It might even be the case
that different symptom dimensions are associated with relationship
with friends in the acute phases of psychotic disorders.
Conclusions
Treatment of negative symptoms and hostility may be
important for enabling patients with psychotic disorders to engage
in friendships. However, the limited effectiveness of currently
available treatments for negative symptoms, the reduced adher-
ence to treatment of patients with high levels of hostility, and the
significant number of patients that do not have friendships despite
low levels of negative symptoms and hostility, suggest that further
therapeutic interventions and support need to be developed to
address the difficulties of patients with schizophrenia in establish-
ing and maintaining friendships.
Experimental studies are required to longitudinally explore the
correlations between symptom domains of psychotic disorders and
friendships and to assess to what extent effective treatment of
negative symptoms and hostility might indeed be followed by more
patient friendships.
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